Intensity Therapeutics, Inc.

8-K Shareholder vote results Jun 16, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) Mar 27, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Other events Mar 23, 2026 8-K Other events Mar 6, 2026 8-K Results of operations (earnings release) Mar 5, 2026 8-K Modified rights of security holders; Amended charter or bylaws; Other events Feb 13, 2026 8-K Delisting notice or listing-rule failure Dec 5, 2025 8-K Other events Dec 4, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Entered a material agreement; Other events Oct 31, 2025 8-K Shareholder vote results Oct 23, 2025 8-K Other events Sep 10, 2025 8-K Amended charter or bylaws; Other events Aug 12, 2025 8-K Results of operations (earnings release) Aug 7, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Other events Aug 4, 2025 8-K Shareholder vote results Jul 18, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 13, 2025 8-K Delisting notice or listing-rule failure Jun 6, 2025 8-K Delisting notice or listing-rule failure May 20, 2025 8-K Results of operations (earnings release) May 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Entered a material agreement; Other events Apr 25, 2025 8-K Regulation FD disclosure Apr 23, 2025 8-K Results of operations (earnings release) Mar 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 13, 2025 8-K Entered a material agreement; Other events Nov 22, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Director or officer change Oct 23, 2024 8-K Results of operations (earnings release) Aug 8, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Director or officer change; Shareholder vote results Jul 17, 2024 8-K Entered a material agreement Jul 3, 2024 8-K Director or officer change May 24, 2024 8-K Director or officer change May 15, 2024